Integer EV/EBIT ITGR
Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2012.
- Today, Oct 23, 2026
- 29.7×
- 10-year median
- 25.4×
- Against its 10-year history
- 84th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 14.8× to 77.2×
- Peer median
- 22.0×
Integer's EV/EBIT is 29.7× as of Oct 23, 2026.
That is above its ten-year median of 25.4×, higher than on 84% of days in the last ten years.
Over that time it ranged from 14.8× in Oct 2025 to 77.2× in Nov 2016.
The median for 6 medical device stocks of a similar size is 22.0×.
EV/EBIT over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 29.7× | 16.7× | 29.8× |
| 2025 | 17.0× | 14.8× | 29.5× |
| 2024 | 28.2× | 24.7× | 30.4× |
| 2023 | 25.0× | 21.0× | 28.6× |
| 2022 | 26.5× | 21.2× | 27.8× |
| 2021 | 24.3× | 23.1× | 43.5× |
| 2020 | 38.4× | 15.7× | 38.6× |
| 2019 | 19.9× | 18.4× | 24.2× |
| 2018 | 21.5× | 20.8× | 33.0× |
| 2017 | 25.9× | 21.8× | 42.3× |
| 2016 | 39.1× | 27.8× | 214× |
| 2015 | 41.4× | 18.5× | 46.5× |
| 2014 | 18.8× | 16.6× | 24.2× |
| 2013 | 23.5× | 20.3× | 34.2× |
| 2012 | 20.6× | 13.0× | 20.7× |
Against its peers
Companies in Medical - Devices nearest Integer's size, closest first, today.
| Company | EV/EBIT |
|---|---|
| ITGRInteger | 29.7× |
| LIVNLivaNova | 22.6× |
| TMDXTransMedics | 34.7× |
| CNMDCONMED | 20.6× |
| ZBHZimmer Biomet | 21.5× |
| DXCMDexCom | 25.3× |
| GEHCGE HealthCare Technologies | 14.7× |
| Peer median | 22.0× |
Where Integer ranks
What the EV/EBIT tells you
What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.
Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.
More on Integer
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.